Roblox Insider Sold Shares Worth $620,100, According to a Recent SEC Filing-March 2024-www.financetom.com

Roblox Insider Sold Shares Worth $620,100, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Roblox Insider Sold Shares Worth $620,100, According to a Recent SEC Filing

Jun 24, 2025 1:39 PM

04:12 PM EDT, 06/24/2025 (MT Newswires) -- Matthew D Kaufman, Chief Safety Officer, on June 20, 2025, sold 6,000 shares in Roblox ( RBLX ) for $620,100. Following the Form 4 filing with the SEC, Kaufman has control over a total of 319,223 Class A common shares of the company, with 319,223 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1315098/000131509825000214/xslF345X05/wk-form4_1750795647.xml

Previous page： Medicenna Says New Data Shows MDNA11 Ability to Promote Anti-tumor Response Next page： Carter's Q4 Earnings Beat Expectations, CEO Warns Of Impact From Lower Pricing In H1

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Medicenna Says New Data Shows MDNA11 Ability to Promote Anti-tumor Response

Feb 25, 2025

08:55 AM EST, 02/25/2025 (MT Newswires) -- Medicenna Therapeutics ( MDNAF ) on Tuesday said new data from its ABILITY-1 study show a significant expansion of certain key immune cell subsets associated with durable anti-tumor response. The Ability-1 study, which is evaluating Medicenna's lead candidate MDNA11 alone or with Merck's Keytruda in patients with advanced solid tumors, also showed that...

Carter's Q4 Earnings Beat Expectations, CEO Warns Of Impact From Lower Pricing In H1

Feb 25, 2025

Carter’s, Inc. shares traded lower in the premarket session on Tuesday. The company reported fourth-quarter adjusted earnings per share of $2.39, beating the street view of $1.92. Quarterly sales of $859.71 million (+0.2% year over year) outpaced the analyst consensus estimate of $837.575 million amid continued momentum in the company’s retail businesses in Mexico and Canada. U.S. wholesale net sales increased 7.3%, U.S. retail and international...

Eli Lilly to Acquire Organovo's FXR Program

Feb 25, 2025

08:53 AM EST, 02/25/2025 (MT Newswires) -- Eli Lilly ( LLY ) has agreed to acquire Organovo Holdings' ( ONVO ) FXR program, including its lead asset FXR314, Organovo ( ONVO ) said Tuesday. The consideration is an upfront payment of $10 million and potential milestone payments of up to $50 million, Organovo ( ONVO ) said, adding that Eli...

Feb 25, 2025

...